Aromasin Exemestane 25mg kapli tablet eksemestan

[Product Name] Aromasin (Exemestane Tablets)

[English Name] Exemestane

[Specification] 25 mg × 30 tablets/box

[Manufacturer] Pfizer Inc.

Exemestane (brand names include Aromasin) is a medication used to treat specific types of breast cancer. It belongs to a class of drugs known as aromatase inhibitors and is primarily used for the treatment of hormone receptor-positive breast cancer in postmenopausal women. The following is a basic overview of the instructions for using Exemestane tablets; please note that the actual product package insert contains more detailed information, and patients should carefully read it and follow their physician's specific instructions prior to use.

[Key Indications]

Adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women: Exemestane is typically used in patients who have already completed 2 to 3 years of tamoxifen therapy, in order to further reduce the risk of cancer recurrence. This sequential therapy helps improve the patient's long-term survival rate and disease-free survival period.

Treatment of advanced or metastatic breast cancer in postmenopausal women: For postmenopausal women with hormone receptor-positive breast cancer who no longer respond to other anti-estrogen therapies (such as tamoxifen), Exemestane may be used as a subsequent treatment option.

Exemestane works by irreversibly binding to and inactivating the enzyme aromatase, thereby reducing the production of estrogen within the body. Since certain types of breast cancer cells rely on estrogen for growth, reducing estrogen levels can help control the development and spread of the tumor.

It is important to note that Exemestane is indicated only for postmenopausal women, as its mechanism of action relies on a low-estrogen internal environment—a condition that cannot be achieved in premenopausal women.

[Dosage and Administration]

Method of Administration

Oral: Exemestane tablets should be swallowed whole and may be taken either with food or on an empty stomach. It is recommended to take the medication at a fixed time each day to maintain stable blood drug concentrations.

Recommended Dosage

Standard Dosage: For most indications—including the adjuvant treatment of hormone receptor-positive early breast cancer and the treatment of advanced or metastatic breast cancer in postmenopausal women—the standard recommended dosage is 25 mg once daily. [Precautions]

Exemestane is indicated only for postmenopausal women, as it functions by reducing estrogen levels in the body—an effect that cannot be effectively achieved in premenopausal women.

If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule; do not take a double dose to make up for the missed one.

During treatment, your doctor may schedule periodic check-ups—including blood tests and bone density assessments—as exemestane may increase the risk of osteoporosis.

[Special Considerations]

For patients with impaired liver or kidney function, while the initial dosage typically remains unchanged, dose adjustments or more frequent monitoring may be required based on the individual patient's response.

Patients should not discontinue the medication or alter the dosage on their own initiative unless directed to do so by a healthcare provider.

[Side Effects]

Common side effects may include, but are not limited to:

Hot flashes

Joint pain or muscle pain

Fatigue

Headache

High blood pressure

Less common but serious side effects may include cardiac issues, severe allergic reactions, etc. If you experience any unusual symptoms or if side effects worsen, please contact your healthcare provider immediately.

[Warnings]

Do not discontinue the medication or alter the dosage on your own unless directed by your doctor.

Before initiating treatment, ensure that you inform your doctor of all medications you are currently taking (including prescription drugs, over-the-counter medications, vitamins, and herbal supplements), as they may interact with exemestane.

Please be sure to consult your doctor or pharmacist for detailed medication instructions, and carefully read the package insert provided with the medication. The information provided above is for informational purposes only and should not be considered a substitute for professional medical advice. During the course of exemestane treatment, it is crucial to adhere to your doctor's instructions and attend scheduled follow-up appointments to ensure the safe and effective use of this medication. Product Specifications

Product Name: Aromasin (Exemestane) Tablets – 25 mg * 30 Tablets/Box

Common Name: Aromasin (Exemestane) Tablets

Active Ingredient: Exemestane

Dosage Form: Tablets

Specification: 25 mg * 30 tablets per box

Manufacturer: Pfizer Inc.

Indications:

*   Adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women: Exemestane is typically used in patients who have already completed 2 to 3 years of tamoxifen therapy, in order to further reduce the risk of cancer recurrence. This sequential therapy helps to improve the patient's long-term survival rate and disease-free survival.

*   Treatment of advanced or metastatic breast cancer in postmenopausal women: For postmenopausal women with hormone receptor-positive breast cancer who no longer respond to other anti-estrogen therapies (such as tamoxifen), Exemestane serves as a subsequent treatment option.

Usage and Dosage:

Method of Administration:

*   Oral Administration: Exemestane tablets should be swallowed whole and may be taken either with food or on an empty stomach. It is recommended to take the medication at a fixed time each day to maintain stable blood drug concentrations.

Recommended Dosage:

*   Standard Dosage: For most indications—including the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as the treatment of advanced or metastatic breast cancer—the standard recommended dosage is 25 mg once daily.